News for ldri
September 15, 2020
Baptiste Buisseret - thesis defence
Effect of oxygenated derivatives of endocannabinoids on mechanical hyperalgesia induced by peripheral inflammation. Baptiste BUISSERET, Bioanalysis and Pharmacology of Bioactive Lipids Research Group, LDRI Supervisor: Prof. Giulio G. Muccioli – Co-supervisor: Dr. Mireille Alhouayek...Click to know more
September 14, 2020
Thibaut Fourniols - thesis defence
Lipid nanocapsules as a delivery platform to tackle colorectal cancer microenvironment Thibaut Fourniols, Advanced Drug Delivery and Biomaterials (ADDB) Promotor: Prof. Véronique Préat Related references: Inhibition of colorectal cancer-associated fibroblasts by lipid...Click to know more
June 23, 2020
4 virtual PhD defenses for 4 real new doctors !!
"Despite the « lockdown », I’m glad to have been able to present my PhD thesis in a “videoconference style”, surrounded (1.5 meters away) by my family and a few friends after all." May 2020 Alice Ameryckx (Medicinal Chemistry/Cellular and...Click to know more
May 12, 2020
Staphylococcus aureus: a hibernating bacteria!
This is what researchers from the UCLouvain Louvain Drug Research Institute (LDRI) have managed to demonstrate. Why doesn’t Staphylococcus aureus respond to antibiotics? And why, when treatment appears to have worked and is stopped, are infection relapses frequent? To escape antibiotics and...Click to know more
May 06, 2020
At the LDRI, our researchers contribute actively to help...
“Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions”. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188032/ Laure Elens, PhD, Loralie J. Langman, PhD, Dennis A. Hesselink, MD, PhD,...Click to know more